Related references
Note: Only part of the references are listed.Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Changes in anxiety and depression symptoms associated to the outcome of MOH: A post-hoc analysis of the Comoestas Project
Sara Bottiroli et al.
CEPHALALGIA (2018)
The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicentre study
Cristina Tassorelli et al.
CEPHALALGIA (2017)
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
Zsolt Hepp et al.
CEPHALALGIA (2017)
Lasting improvement of medication-overuse headache after brief intervention - a long-term follow-up in primary care
E. S. Kristoffersen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
The Effectiveness of Treatments for Patients With Medication Overuse Headache: A Systematic Review and Meta-Analysis
Maaike J. de Goffau et al.
JOURNAL OF PAIN (2017)
Medication overuse headache An entrenched idea in need of scrutiny
Ann I. Scher et al.
NEUROLOGY (2017)
Predictors of successful primary care detoxification treatment for medication-overuse headache
E. S. Kristoffersen et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Medication overuse, healthy lifestyle behaviour and stress in chronic headache: Results from a population-based representative survey
Maria Lurenda Westergaard et al.
CEPHALALGIA (2016)
Detoxification in medication-overuse headache, a retrospective controlled follow-up study: Does care by a headache nurse lead to cure?
J. A. Pijpers et al.
CEPHALALGIA (2016)
Psychological factors associated with failure of detoxification treatment in chronic headache associated with medication overuse
S. Bottiroli et al.
CEPHALALGIA (2016)
Medication-overuse headache: risk factors, pathophysiology and management
Hans-Christoph Diener et al.
NATURE REVIEWS NEUROLOGY (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project)
L. Bendtsen et al.
CEPHALALGIA (2014)
Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial
Paola Sarchielli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Prevalence of chronic headache with and without medication overuse: Associations with socioeconomic position and physical and mental health status
Maria Lurenda Westergaard et al.
PAIN (2014)
Factors associated with a negative outcome of medication-overuse headache: A 3-year follow-up (the 'CARE' protocol)
Grazia Sances et al.
CEPHALALGIA (2013)
Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial
Paolo Rossi et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Personality traits in chronic daily headache patients with and without psychiatric comorbidity: an observational study in a tertiary care headache center
Marialuisa Rausa et al.
JOURNAL OF HEADACHE AND PAIN (2013)
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
Stephen D. Silberstein et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Detoxification for medication overuse headache is not necessary
Hans-Christoph Diener
CEPHALALGIA (2012)
Detoxification for medication overuse headache is the primary task
Jes Olesen
CEPHALALGIA (2012)
Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: A comparison of two consecutive treatment methods in an open-label design
Signe B. Munksgaard et al.
CEPHALALGIA (2012)
The cost of headache disorders in Europe: the Eurolight project
M. Linde et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Treatment-Resistant Medication Overuse Headache Can Be Cured
Signe B. Munksgaard et al.
HEADACHE (2012)
Drug-dependence behaviour and outcome of medication-overuse headache after treatment
Ilenia Corbelli et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Dependence scores predict prognosis of medication overuse headache: A prospective cohort from the Akershus study of chronic headache
Christofer Lundqvist et al.
PAIN (2012)
Risk factors for medication-overuse headache: An 11-year follow-up study. The Nord-Trondelag Health Studies
Knut Hagen et al.
PAIN (2012)
A randomized controlled trial on medication-overuse headache: outcome after 1 and 4 years
K. Hagen et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
In-patient versus out-patient withdrawal programmes for medication overuse headache: A 2-year randomized trial
C. Creac'h et al.
CEPHALALGIA (2011)
Efficacy and Tolerability of Pregabalin Versus Topiramate in the Prophylaxis of Chronic Daily Headache With Analgesic Overuse: An Open-Label Prospective Study
Barbara Rizzato et al.
CLINICAL NEUROPHARMACOLOGY (2011)
Reduction in medication-overuse headache after short information. The Akershus study of chronic headache
R. B. Grande et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache
P. Rossi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Treatment of medication overuse headache - guideline of the EFNS headache panel
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program
Sheena K. Aurora et al.
HEADACHE (2011)
A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study
Knut Hagen et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study
Giorgio Sandrini et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Risk factors in medication-overuse headache: A 1-year follow-up study (care II protocol)
G. Sances et al.
CEPHALALGIA (2010)
Predictors of outcome of the treatment programme in a multidisciplinary headache centre
Rigmor Jensen et al.
CEPHALALGIA (2010)
Prevalence of headache in Europe: a review for the Eurolight project
Lars Jacob Stovner et al.
JOURNAL OF HEADACHE AND PAIN (2010)
Management of medication overuse headache: 1-year randomized multicentre open-label trial
K. Hagen et al.
CEPHALALGIA (2009)
Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse
H-C Diener et al.
CEPHALALGIA (2009)
Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy
M. G. Boe et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headache
R. B. Grande et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study
P. Rossi et al.
CEPHALALGIA (2008)
In-patient vs. day-hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment: results at one-year follow-up
Licia Grazzi et al.
NEUROLOGICAL SCIENCES (2008)
Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up
J. Zidverc-Trajkovic et al.
CEPHALALGIA (2007)
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study
H-C Diener et al.
CEPHALALGIA (2007)
Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness
P. Zeeberg et al.
CEPHALALGIA (2006)
Medication overuse headache: type I and type II
J. R. Saper et al.
CEPHALALGIA (2006)
Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs
P. Rossi et al.
CEPHALALGIA (2006)
New appendix criteria open for a broader concept of chronic migraine
J Olesen et al.
CEPHALALGIA (2006)
Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine
Daniele Mei et al.
CLINICAL NEUROPHARMACOLOGY (2006)
Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes
ME Bigal et al.
CEPHALALGIA (2004)
Rates and predictors for relapse in medication overuse headache: A 1-year prospective study
Z Katsarava et al.
NEUROLOGY (2003)
Share Paper
